A5040699917- Multiple Sclerosis Research Studies
- Peripheral Neuropathies and Disorders
- Systemic Sclerosis and Related Diseases
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Reproductive System and Pregnancy
- SARS-CoV-2 and COVID-19 Research
- Vitamin D Research Studies
- Neurogenesis and neuroplasticity mechanisms
- Polyomavirus and related diseases
- Neuroinflammation and Neurodegeneration Mechanisms
- Long-Term Effects of COVID-19
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Stress Responses and Cortisol
- Hereditary Neurological Disorders
- Retinal and Optic Conditions
- Health Systems, Economic Evaluations, Quality of Life
- Viral Infections and Immunology Research
- RNA regulation and disease
- Acute Lymphoblastic Leukemia research
- Biomedical Ethics and Regulation
- Delphi Technique in Research
- Effects of Vibration on Health
- vaccines and immunoinformatics approaches
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia
2016-2025
McGill University
2023
Hospital Ramos Mejía
2022
Instituto de Neurología Cognitiva
2012-2020
Hospital Italiano de Buenos Aires
2019
Centre de Recherche Épidémiologie et Statistique
2019
Neuroscience Institute
2019
Mayo Clinic in Florida
2019
Mayo Clinic
2018
Although Vitamin D is best known as a modulator of calcium homeostasis, it also has immune modulating potential. A protective effect on multiple sclerosis supported by the reduced risk associated with sun exposure and use supplements. Moreover, high circulating levels have been lower sclerosis. In this study, we measured 1,25 (OH)2 25 (OH) in patients separated into different clinical subgroups according to disease status. addition, direct effects ex vivo CD4+ T cells myelin-peptide specific...
Vitamin D(3) is best known as a calcium homeostasis modulator; however, it also has immune-modulating potential. In this study, we demonstrated that immunomodulatory effects of vitamin are significantly stronger in females than males multiple sclerosis patients, well healthy subjects. Inhibition self-reactive T cell proliferation and reduction IFN-γ- IL-17-secreting numbers were considerably greater females. Furthermore, the increase IL-10-secreting CD4(+)CD25(+)FoxP3(+) regulatory parallel...
Our objective was to evaluate risk of exacerbations in multiple sclerosis (MS) patients undergoing assisted reproduction technology (ART) infertility treatment.Sixteen with relapsing-remitting MS subjected 26 ART treatment cycles receiving gonadotropin-releasing hormone (GnRH) agonists and recombinant follicle-stimulating were studied prospectively. The baseline study period encompassed 12 months prior the first cycle 9 after final cycle. Neurological examinations, brain magnetic resonance...
In recent years, neurologists are noticing that evaluation of multiple sclerosis (MS) patients based on combining relapses, disability progression, and magnetic resonance imaging activity may be insufficient to adequately assess suboptimal responses available therapy. Inclusion quality life (QoL) parameters contribute breach this gap.To evaluate agreement levels between doctor patient perception QoL in MS.A total 700 MS 300 were invited participate a cross-sectional study by answering an...
<b>Objective:</b> To investigate hypothalamic-pituitary-adrenal axis activity in well-defined multiple sclerosis (MS) patient subgroups. <b>Methods:</b> A total of 173 patients with clinically definite MS were studied: 40 primary progressive, 41 secondary 58 relapsing-remitting remission, and 34 during acute relapse. Sixty healthy subjects served as controls. No receiving steroid or other immunomodulatory therapy. Plasma cortisol, adrenocorticotropic hormone (ACTH), dehydroepiandrosterone...
We aimed to examine treatment interventions implemented in patients experiencing neuromyelitis optica spectrum disorders (NMOSD) attacks (frequency, types, and response). Methods Retrospective study. Data on patient demographic, clinical radiological findings, administered treatments were collected. Remission status (complete [CR], partial [PR], no remission [NR]), based changes the EDSS score was evaluated before treatment, during attack, at 6 months. CR analyzed with a generalized...
Objective: Most contemporary data concerning the frequency and causes of multiple sclerosis (MS) misdiagnosis are from North America Europe with different healthcare system structure resources than countries in Latin America. We sought to determine frequency, potential contributors MS patients evaluated at an referral center Argentina. Methods: The study was a retrospective medical record review. included Clinic Fleni between April 2013 March 2021. Diagnoses prior consultation, final...
Our website uses cookies to enhance your experience. By continuing use our site, or clicking "Continue," you are agreeing Cookie Policy | Continue JAMA Neurology HomeNew OnlineCurrent IssueFor Authors Podcast Publications Network Open Cardiology Dermatology Health Forum Internal Medicine Oncology Ophthalmology Otolaryngology–Head & Neck Surgery Pediatrics Psychiatry Archives of (1919-1959) JN Learning / CMESubscribeJobsInstitutions LibrariansReprints Permissions Terms Use Privacy...